These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
601 related items for PubMed ID: 23872669
1. Patatin-like phospholipase domain-containing protein 3 rs738409-G in recipients of liver transplants is a risk factor for graft steatosis. Finkenstedt A, Auer C, Glodny B, Posch U, Steitzer H, Lanzer G, Pratschke J, Biebl M, Steurer M, Graziadei I, Vogel W, Zoller H. Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1667-72. PubMed ID: 23872669 [Abstract] [Full Text] [Related]
3. Noninvasive characterization of graft steatosis after liver transplantation. Karlas T, Kollmeier J, Böhm S, Müller J, Kovacs P, Tröltzsch M, Weimann A, Bartels M, Rosendahl J, Mössner J, Berg T, Keim V, Wiegand J. Scand J Gastroenterol; 2015 Feb; 50(2):224-32. PubMed ID: 25429378 [Abstract] [Full Text] [Related]
4. Effect of PNPLA3 rs738409 variant (I148 M) on hepatic steatosis, necroinflammation, and fibrosis in Japanese patients with chronic hepatitis C. Yasui K, Kawaguchi T, Shima T, Mitsuyoshi H, Seki K, Sendo R, Mizuno M, Itoh Y, Matsuda F, Okanoue T. J Gastroenterol; 2015 Aug; 50(8):887-93. PubMed ID: 25543233 [Abstract] [Full Text] [Related]
5. Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation. Míková I, Neřoldová M, Hubáček JA, Dlouhá D, Jirsa M, Honsová E, Sticová E, Lánská V, Špičák J, Trunečka P. Transplantation; 2020 Mar; 104(3):526-534. PubMed ID: 31356578 [Abstract] [Full Text] [Related]
7. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S. Hepatology; 2011 Mar; 53(3):791-9. PubMed ID: 21319195 [Abstract] [Full Text] [Related]
8. PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease. Tortora R, Rispo A, Alisi A, Imperatore N, Crudele A, Ferretti F, Nobili V, Miele L, Gerbino N, Caporaso N, Morisco F. Nutrients; 2018 Sep 05; 10(9):. PubMed ID: 30189691 [Abstract] [Full Text] [Related]
9. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. Hotta K, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A. BMC Med Genet; 2010 Dec 22; 11():172. PubMed ID: 21176169 [Abstract] [Full Text] [Related]
10. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease]. Xu J, Xin YN, Lü WH, Lin ZH, Zhang DD, Zhang M, Dong QJ, Jiang XJ, Xuan SY. Zhonghua Gan Zang Bing Za Zhi; 2013 Aug 22; 21(8):619-23. PubMed ID: 24119744 [Abstract] [Full Text] [Related]
11. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease. Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML. Surg Obes Relat Dis; 2015 Aug 22; 11(4):888-94. PubMed ID: 25240529 [Abstract] [Full Text] [Related]
12. Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C. Dunn W, O'Neil M, Zhao J, Wu CH, Roberts B, Chakraborty S, Sherman C, Weaver B, Taylor R, Olson J, Olyaee M, Gilroy R, Schmitt T, Wan YJ, Weinman SA. Hepatology; 2014 Feb 22; 59(2):453-60. PubMed ID: 24123231 [Abstract] [Full Text] [Related]
13. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP. Hepatology; 2010 Apr 22; 51(4):1209-17. PubMed ID: 20373368 [Abstract] [Full Text] [Related]
14. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C. Manchiero C, Nunes AKDS, Magri MC, Dantas BP, Mazza CC, Barone AA, Tengan FM. BMC Infect Dis; 2017 Dec 19; 17(1):780. PubMed ID: 29258449 [Abstract] [Full Text] [Related]
15. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. J Pediatr; 2011 May 19; 158(5):740-4. PubMed ID: 21168155 [Abstract] [Full Text] [Related]
16. Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients. Jiménez-Sousa MA, Berenguer J, García-Álvarez M, Gutierrez-Rivas M, Aldámiz-Echevarria T, Tejerina F, Diez C, Vázquez-Morón S, Resino S. AIDS; 2016 Jan 28; 30(3):465-70. PubMed ID: 26760234 [Abstract] [Full Text] [Related]
17. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Sookoian S, Pirola CJ. Hepatology; 2011 Jun 28; 53(6):1883-94. PubMed ID: 21381068 [Abstract] [Full Text] [Related]
18. Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B. Viganò M, Valenti L, Lampertico P, Facchetti F, Motta BM, D'Ambrosio R, Romagnoli S, Dongiovanni P, Donati B, Fargion S, Colombo M. Hepatology; 2013 Oct 28; 58(4):1245-52. PubMed ID: 23564580 [Abstract] [Full Text] [Related]